Modification of anti-tumor immunity by tolerogenic dendritic cells

References

• Ayroldi E, Cannarile L, Migliorati G, et al. Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways. FASEB J. 2012;26:4805–4820.
   PubMed Web of Science ®Google Scholar
• Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335:2–13.
   PubMed Web of Science ®Google Scholar
• Strehl C, Buttgereit F. Optimized glucocorticoid therapy: teaching old drugs new tricks. Mol Cell Endocrinol. 2013;380:32–40.
   PubMed Web of Science ®Google Scholar
• Meijsing SH. Mechanisms of glucocorticoid-regulated gene transcription. Adv Exp Med Biol. 2015;872:59–81.
   PubMed Web of Science ®Google Scholar
• Vandevyver S, Dejager L, Libert C. Comprehensive overview of the structure and regulation of the glucocorticoid receptor. Endocr Rev. 2014;35:671–693.
   PubMed Web of Science ®Google Scholar
• Lu NZ, Cidlowski JA. Glucocorticoid receptor isoforms generate transcription specificity. Trend Cell Biol. 2006;16:301–307.
   PubMed Web of Science ®Google Scholar
• Petta I, Dejager L, Ballegeer M, et al. The interactome of the glucocorticoid receptor and its influence on the actions of glucocorticoids in combatting inflammatory and infectious diseases. Microbiol Mol Biol Rev. 2016;80:495–522.
   PubMedGoogle Scholar
• Rozkova D, Horvath R, Bartunkova J, et al. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin Immunol. 2006;120:260–271.
   PubMed Web of Science ®Google Scholar
• Piemonti L, Monti P, Allavena P, et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol. 1999;162:6473–6481.
   PubMed Web of Science ®Google Scholar
• Butts CL, Shukair SA, Duncan KM, et al. Effects of dexamethasone on rat dendritic cell function. Horm Metab Res. 2007;39:404–412.
   PubMed Web of Science ®Google Scholar
• Pan J, Ju D, Wang Q, et al. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett. 2001;76:153–161.
   PubMed Web of Science ®Google Scholar
• Adler HS, Steinbrink K. Tolerogenic dendritic cells in health and disease: friend and foe! Eur J Dermatol. 2007;17:476–491. Epub 2007/10/24.
   PubMed Web of Science ®Google Scholar
• Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function*. Annu Rev Immunol. 2000;18:309–345.
   PubMed Web of Science ®Google Scholar
• Erlacher M, Knoflach M, Stec IE, et al. TCR signaling inhibits glucocorticoid-induced apoptosis in murine thymocytes depending on the stage of development. Eur J Immunol. 2005;35:3287–3296.
   PubMed Web of Science ®Google Scholar
• Yakimchuk K, Chen L, Hasni MS, et al. The selective impact of transgenically expressed glucocorticoid receptor on T cells. Autoimmunity. 2015;48:117–124.
   PubMed Web of Science ®Google Scholar
• Braitch M, Harikrishnan S, Robins RA, et al. Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol Scand. 2009;119:239–245.
   PubMed Web of Science ®Google Scholar
• Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol. 2004;114:1425–1433.
   PubMed Web of Science ®Google Scholar
• Zhou X, Kong N, Zou H, et al. Therapeutic potential of TGF-beta-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases. Autoimmunity. 2011;44:43–50.
   PubMed Web of Science ®Google Scholar
• Harry RA, Anderson AE, Isaacs JD, et al. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis. 2010;69:2042–2050.
   PubMed Web of Science ®Google Scholar
• Dinesh RK, Skaggs BJ, La Cava A, et al. CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun Rev. 2010;9:560–568.
   PubMed Web of Science ®Google Scholar
• Tsai S, Clemente-Casares X, Santamaria P. CD8(+) Tregs in autoimmunity: learning “self”-control from experience. Cell Mol Life Sci. 2011;68:3781–3795.
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14:1014–1022.
   PubMed Web of Science ®Google Scholar
• Galetto G, Law LW, Rogers MJ. The Rauscher-MuLV-induced leukemia, RBL-5, bears two tumor-associated transplantation antigens expressed on distinct molecules. Int J Cancer. 1985;36:713–719.
   PubMed Web of Science ®Google Scholar
• Zhou F, Rouse BT, Huang L. Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study. Cancer Res. 1992;52:6287–6291.
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187–376.
   PubMed Web of Science ®Google Scholar
• Spallanzani RG, Torres NI, Avila DE, et al. Regulatory dendritic cells restrain NK cell IFN-gamma production through mechanisms involving NKp46, IL-10, and MHC class I-specific inhibitory receptors. J Immunol. 2015;195:2141–2148.
   PubMed Web of Science ®Google Scholar
• Chiossone L, Chaix J, Fuseri N, et al. Maturation of mouse NK cells is a 4-stage developmental program. Blood. 2009;113:5488–5496.
   PubMed Web of Science ®Google Scholar
• Girardi M, Oppenheim DE, Steele CR, et al. Regulation of cutaneous malignancy by gammadelta T cells. Science. 2001;294:605–609.
   PubMed Web of Science ®Google Scholar
• Hayakawa Y, Kelly JM, Westwood JA, et al. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. J Immunol. 2002;169:5377–5381.
   PubMed Web of Science ®Google Scholar
• Rifa'i M, Kawamoto Y, Nakashima I, et al. Essential roles of CD8 + CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med. 2004;200:1123–1134.
   PubMed Web of Science ®Google Scholar
• Endharti AT, Rifa IM, Shi Z, et al. Cutting edge: CD8 + CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol. 2005;175:7093–7097.
   PubMed Web of Science ®Google Scholar
• Levings MK, Gregori S, Tresoldi E, et al. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25 + CD4+ Tr cells. Blood. 2005;105:1162–1169.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E, Schuler G, et al. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 2000;192:1213–1222.
   PubMed Web of Science ®Google Scholar
• Zhou F, Ciric B, Zhang GX, et al. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis. Clinical and experimental. Clin Exp Immunol. 2014;178:447–458.
   PubMed Web of Science ®Google Scholar
• Mayer CT, Floess S, Baru AM, et al. CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity. Eur J Immunol. 2011;41:716–725.
   PubMed Web of Science ®Google Scholar
• Wang LX, Li Y, Yang G, et al. CD122 + CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice. Eur J Immunol. 2010;40:1375–1385.
   PubMed Web of Science ®Google Scholar
• Chaput N, Louafi S, Bardier A, et al. Identification of CD8 + CD25 + Foxp3+ suppressive T cells in colorectal cancer tissue. Gut. 2009;58:520–529.
   PubMed Web of Science ®Google Scholar
• Kiniwa Y, Miyahara Y, Wang HY, et al. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res. 2007;13:6947–6958.
   PubMed Web of Science ®Google Scholar
• Lourenco EV, La Cava A. Natural regulatory T cells in autoimmunity. Autoimmunity. 2011;44:33–42.
   PubMed Web of Science ®Google Scholar
• Ohkura N, Sakaguchi S. Maturation of effector regulatory T cells. Nat Immunol. 2011;12:283–284.
   PubMed Web of Science ®Google Scholar
• Cretney E, Xin A, Shi W, et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol. 2011;12:304–311.
   PubMed Web of Science ®Google Scholar
• Rogatsky I, Chandrasekaran U, Manni M, et al. Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity. Autoimmunity. 2014;47:242–255.
   PubMed Web of Science ®Google Scholar